NCT07022938View on ClinicalTrials.gov

Nutritional Supplement for Treating Chemotherapy Induced Neuropathy

PHASE4CompletedINTERVENTIONAL
Enrollment

71

Participants

Timeline

Start Date

November 1, 2021

Primary Completion Date

January 31, 2025

Study Completion Date

January 31, 2025

Conditions
CancerNeuropathyChemotherapy Induced Pain NeuropathyChemotherapy-Induced Peripheral Neuropathy
Interventions
DIETARY_SUPPLEMENT

Epineuron

Palmitoylethanolamide (PEA, 300 mg), Superoxide Dismutase (SOD, 70 UI), Alpha Lipoic Acid (ALA, 300 mg), vitamins B6 (1.5 mg), B1 (1.1 mg), B12 (2.5 mcg), E (7.5 mg), Nicotinamide (9 mg) and minerals (Mg 30 mg, Zn 2.5 mg) in one tablet

DIETARY_SUPPLEMENT

Placebo Tablets

placebo tablet without active ingredients

Trial Locations (1)

Unknown

University General Hospital of Thessaloniki AHEPA, Thessaloniki

All Listed Sponsors
lead

Aristotle University Of Thessaloniki

OTHER